These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4085913)

  • 1. Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis.
    Lenz K; Druml W; Kleinberger G; Hörtnagl H; Laggner A; Schneeweiss B; Deutsch E
    Gut; 1985 Dec; 26(12):1385-6. PubMed ID: 4085913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.
    Lenz K; Hörtnagl H; Druml W; Grimm G; Laggner A; Schneeweisz B; Kleinberger G
    Gut; 1989 Jan; 30(1):90-6. PubMed ID: 2646181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor.
    Lenz K; Hörtnagl H; Druml W; Reither H; Schmid R; Schneeweiss B; Laggner A; Grimm G; Gerbes AL
    Gastroenterology; 1991 Oct; 101(4):1060-7. PubMed ID: 1832407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin].
    Gülberg V; Luppa P; Pauletzki J; Paumgartner G; Gerbes AL
    Z Gastroenterol; 1998 Dec; 36(12):1053-8. PubMed ID: 10025057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocirculatory failure: diverse pathogeneses deserve diverse therapies.
    Cohn JN
    Hepatology; 1990 Mar; 11(3):510-1. PubMed ID: 2312065
    [No Abstract]   [Full Text] [Related]  

  • 6. [Successful therapy of hepatorenal syndrome with norepinephrine].
    Pehl C; Schepp W
    Z Gastroenterol; 2000 Dec; 38(12):945-50. PubMed ID: 11194884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.
    Gülberg V; Bilzer M; Gerbes AL
    Hepatology; 1999 Oct; 30(4):870-5. PubMed ID: 10498636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
    Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
    Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent effects of oral misoprostol on renal function in alcoholic cirrhosis.
    Wong F; Massie D; Hsu P; Dudley F
    Gastroenterology; 1994 Mar; 106(3):658-63. PubMed ID: 8119537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
    Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
    Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of POR-8 in the management of burned children.
    De Mey A; Govaerts MJ; Widera I
    Acta Anaesthesiol Belg; 1985 Sep; 36(3):189-93. PubMed ID: 3904301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological vasoconstriction in gynecology. Results obtained with ornithine-8-vasopressin].
    Saccà V; Testori P; Valsecchi A
    Riv Ital Ginecol; 1980; 59(1):59-63. PubMed ID: 7466197
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure.
    Gülberg V; Møller S; Henriksen JH; Gerbes AL
    Gut; 2000 Dec; 47(6):852-7. PubMed ID: 11076886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of resistant hypotension with ornipressin. A case report.
    Freedman M; Kundig H; Leiman BC
    S Afr Med J; 1985 Jan; 67(1):29-31. PubMed ID: 3966182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of a new posterior pituitary derivative (ornithine-8-vasopressin) with vasoconstrictive action in gynecologic surgery].
    Spitali R; Piccione E; Baschieri L
    Clin Ter; 1980 Oct; 95(2):179-89. PubMed ID: 7471654
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal water handling in rats with decompensated liver cirrhosis.
    Jonassen TE; Christensen S; Kwon TH; Langhoff S; Salling N; Nielsen S
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1101-9. PubMed ID: 11097629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-pharmacological case (2). Bradycardia and ventricular tachycardia of the torsades de pointes type as a side effect of vasopressin: 3 case reports].
    Kupferschmidt H; Meier CH; Sulzer M; Meier PJ; Bühler H
    Praxis (Bern 1994); 1996 Mar; 85(11):340-3. PubMed ID: 8643894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of POR 8 in the treatment of burns].
    De Mey A; Capouet V; Govaerts M
    Rev Med Brux; 1989 Apr; 10(4):160-2. PubMed ID: 2664963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis].
    Genoud E; Gonvers JJ; Schaller MD; Essinger A; Haller E; Brunner HR
    Schweiz Med Wochenschr; 1986 Apr; 116(15):463-9. PubMed ID: 3518053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.